Simplex Trading
TNYA icon

Simplex Trading’s Tenaya Therapeutics TNYA Stock Holding History

Simplex Trading’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.1K Buy
50,655
+12,112
+31% +$8.94K ﹤0.01% 6230
2025
Q4 		$27.4K Sell
38,543
-73,389
-66% -$99.8K ﹤0.01% 6188
2025
Q3 		$181K Buy
111,932
+103,374
+1,208% +$104K ﹤0.01% 5061
2025
Q2 		$5K Buy
8,558
+3,337
+64% +$1.7K ﹤0.01% 7779
2025
Q1 		$2K Sell
5,221
-43,047
-89% -$42.5K ﹤0.01% 8083
2024
Q4 		$69K Buy
48,268
+47,560
+6,718% +$107K ﹤0.01% 5540
2024
Q3 		$1K Sell
708
-8,844
-93% -$25K ﹤0.01% 8285
2024
Q2 		$29K Buy
9,552
+5,914
+163% +$24.4K ﹤0.01% 6592
2024
Q1 		$19K Sell
3,638
-3,105
-46% -$14.9K ﹤0.01% 7140
2023
Q4 		$21K Buy
6,743
+6,279
+1,353% +$13.6K ﹤0.01% 6904
2023
Q3 		$1K Buy
+464
New +$1.94K ﹤0.01% 8429
2023
Q2 		– Sell
-9,813
Closed -$57K – 9947
2023
Q1 		$27K Buy
+9,813
New +$27.6K ﹤0.01% 6607
2022
Q4 		– Sell
-3,000
Closed -$7.32K – 10449
2022
Q3 		$8K Buy
+3,000
New +$14K ﹤0.01% 8445

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's TNYA Position: Q1 2026 in Review

Simplex Trading increased its Tenaya Therapeutics (TNYA) stake by 31% in Q1 2026, buying an estimated $8.94K and bringing the position to 50,655 shares worth $35.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6230.

Simplex Trading first reported a position in TNYA in Q3 2022 and has held it in 13 quarters since. The position peaked at $181K in Q3 2025. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Simplex Trading held 50,655 shares of Tenaya Therapeutics worth $35.1K as of Q1 2026.
  • Simplex Trading bought 12,112 Tenaya Therapeutics shares in Q1 2026, an estimated $8.94K.
  • Tenaya Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6230 holding.
  • Simplex Trading first reported a position in Tenaya Therapeutics in Q3 2022 and has held it in 13 quarters since.
  • Simplex Trading's Tenaya Therapeutics position peaked at $181K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.